Related Experiment Video
Updated: Oct 23, 2025

08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.0K
Virtual reality for pain management in advanced heart failure: A randomized controlled study
Hunter Groninger1,2, Diana Stewart2, Julia M Fisher3
1Georgetown University Medical Center, Washington, DC, USA.
Palliative Medicine
|August 25, 2021
Summary
Virtual reality significantly reduced pain in hospitalized heart failure patients compared to guided imagery. This non-pharmacologic approach shows promise for pain management in advanced heart failure.
Area of Science:
- Cardiology
- Pain Management
- Virtual Reality Technology
Background:
- Hospitalized patients with advanced heart failure frequently experience acute and chronic pain.
- Virtual reality (VR) has shown potential in various clinical settings, but its impact on pain in heart failure patients is unstudied.
- This study addresses the need for effective non-pharmacologic pain management strategies in this population.
Purpose of the Study:
- To evaluate the effect of a virtual reality experience on self-reported pain, quality of life, and distress in advanced heart failure patients.
- To compare the efficacy of virtual reality against a 2D guided imagery control for pain management.
- To assess patient satisfaction with the virtual reality intervention.
Main Methods:
- A single-center prospective randomized controlled study was conducted with 88 hospitalized advanced heart failure patients.
- The primary outcome measured was the change in self-reported pain scores using a numerical rating scale (0-10).
- Secondary outcomes included changes in quality of life, general distress, and participant satisfaction.
Main Results:
- Both virtual reality and guided imagery significantly reduced pain scores.
- Virtual reality demonstrated a comparatively greater reduction in pain (1.5 units) versus guided imagery (p=0.0011).
- Quality of life and general distress scores did not change significantly; 89% of participants would use the intervention again.
Conclusions:
- Virtual reality may serve as an effective non-pharmacologic adjuvant therapy for pain management in hospitalized heart failure patients.
- The findings support the use of VR for pain relief in this specific clinical population.
- Further research can explore VR's long-term benefits and integration into standard care.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
62
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
62
Heart Failure V: Medical Management
52
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
Heart Failure VII: Nursing Interventions
194
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
194
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
587
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
587

